Global Globular Protein Market

Globular Protein Comprehensive Study by Type (Recombinant Globular Protein, Bovine Globular Protein, Human Globular Protein), Application (Therapeutics, Vaccine, Other), End Use (Hospitals, Clinics) Players and Region - Global Market Outlook to 2030

Globular Protein Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 6.1%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Globular Protein
The rapid speed of study in the life sciences is producing a huge amount of new knowledge that can be used for good in manufacturing, agriculture, and medicine. Proteins serve several purposes in cellular physiology, including structural building blocks, catalyzing biochemical reactions, conducting regulatory functions, and self-assembling into complex molecular devices, such as contractile fibers in cell motility or channels that regulate ion flow through cell membranes, when paired with other proteins. Globular proteins have a spherical three-dimensional structure that forms naturally and is sustained by interactions between amino acid side chains. The amino acid composition of different globular proteins varies, which is important for nutritional value. Protease inhibitors co-fractionated with the main ingredient are thought to be a powerful antinutritional element. Due to recent advances in vaccine and therapeutics in Healthcare, market for globular proteins is set ton flourish.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR6.1%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States and Chinese Players will contribute the maximum growth to Global Globular Protein market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

CSL Limited (Australia), Grifols (Spain), Shire (Baxalta) (United States), Octapharma (Switzerland), Hualan Bio (China), China Biologic Products Holdings Inc (China), Thermo Fisher Scientific (United States), Delta Biotechnology Limited (United Kingdom), LFB S.A. (France) and Merck & Co. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Kedrion (United States) and Ventria (InVitria) (United States).

Segmentation Overview
AMA Research has segmented the market of Global Globular Protein market by Type (Recombinant Globular Protein, Bovine Globular Protein and Human Globular Protein), Application (Therapeutics, Vaccine and Other) and Region.



On the basis of geography, the market of Globular Protein has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Use, the sub-segment i.e. Hospitals will boost the Globular Protein market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technical Progress in Biotech Industry

Market Growth Drivers:
Prevalence of Diseases and Infections, Increasing Research and Development in Biotech and Rising Demand for Protein-Based Fitness Supplements

Challenges:
Fierce Competitive Pressure

Restraints:
Lack of Trained Professionals

Opportunities:
Growing Healthcare Infrastructure and Low Penetration in Emerging Regions

Market Leaders and their expansionary development strategies
In October 2023, Archer Daniels Midland (ADM) acquired Neovia, a European leader in animal nutrition, for €1.54 billion. This merger aimed to strengthen ADM's position in the animal nutrition market and expand its reach in Europe.
In March 2021, DuPont Nutrition & Biosciences launched a new line of enzyme solutions for improving the digestibility of plant-based proteins. These enzymes aimed to make plant-based proteins more digestible and nutritious for animals.


Key Target Audience
Biotech Companies, New Entrants and Investors, Pharmaceutical Products Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Recombinant Globular Protein
  • Bovine Globular Protein
  • Human Globular Protein
By Application
  • Therapeutics
  • Vaccine
  • Other
By End Use
  • Hospitals
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Diseases and Infections
      • 3.2.2. Increasing Research and Development in Biotech
      • 3.2.3. Rising Demand for Protein-Based Fitness Supplements
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Biotech Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Globular Protein, by Type, Application, End Use and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Globular Protein (Value)
      • 5.2.1. Global Globular Protein by: Type (Value)
        • 5.2.1.1. Recombinant Globular Protein
        • 5.2.1.2. Bovine Globular Protein
        • 5.2.1.3. Human Globular Protein
      • 5.2.2. Global Globular Protein by: Application (Value)
        • 5.2.2.1. Therapeutics
        • 5.2.2.2. Vaccine
        • 5.2.2.3. Other
      • 5.2.3. Global Globular Protein by: End Use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
      • 5.2.4. Global Globular Protein Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Globular Protein: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CSL Limited (Australia)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Grifols (Spain)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Shire (Baxalta) (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Octapharma (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hualan Bio (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. China Biologic Products Holdings Inc (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Delta Biotechnology Limited (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LFB S.A. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Merck & Co. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Globular Protein Sale, by Type, Application, End Use and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Globular Protein (Value)
      • 7.2.1. Global Globular Protein by: Type (Value)
        • 7.2.1.1. Recombinant Globular Protein
        • 7.2.1.2. Bovine Globular Protein
        • 7.2.1.3. Human Globular Protein
      • 7.2.2. Global Globular Protein by: Application (Value)
        • 7.2.2.1. Therapeutics
        • 7.2.2.2. Vaccine
        • 7.2.2.3. Other
      • 7.2.3. Global Globular Protein by: End Use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
      • 7.2.4. Global Globular Protein Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Globular Protein: by Type(USD Million)
  • Table 2. Globular Protein Recombinant Globular Protein , by Region USD Million (2018-2023)
  • Table 3. Globular Protein Bovine Globular Protein , by Region USD Million (2018-2023)
  • Table 4. Globular Protein Human Globular Protein , by Region USD Million (2018-2023)
  • Table 5. Globular Protein: by Application(USD Million)
  • Table 6. Globular Protein Therapeutics , by Region USD Million (2018-2023)
  • Table 7. Globular Protein Vaccine , by Region USD Million (2018-2023)
  • Table 8. Globular Protein Other , by Region USD Million (2018-2023)
  • Table 9. Globular Protein: by End Use(USD Million)
  • Table 10. Globular Protein Hospitals , by Region USD Million (2018-2023)
  • Table 11. Globular Protein Clinics , by Region USD Million (2018-2023)
  • Table 12. South America Globular Protein, by Country USD Million (2018-2023)
  • Table 13. South America Globular Protein, by Type USD Million (2018-2023)
  • Table 14. South America Globular Protein, by Application USD Million (2018-2023)
  • Table 15. South America Globular Protein, by End Use USD Million (2018-2023)
  • Table 16. Brazil Globular Protein, by Type USD Million (2018-2023)
  • Table 17. Brazil Globular Protein, by Application USD Million (2018-2023)
  • Table 18. Brazil Globular Protein, by End Use USD Million (2018-2023)
  • Table 19. Argentina Globular Protein, by Type USD Million (2018-2023)
  • Table 20. Argentina Globular Protein, by Application USD Million (2018-2023)
  • Table 21. Argentina Globular Protein, by End Use USD Million (2018-2023)
  • Table 22. Rest of South America Globular Protein, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Globular Protein, by Application USD Million (2018-2023)
  • Table 24. Rest of South America Globular Protein, by End Use USD Million (2018-2023)
  • Table 25. Asia Pacific Globular Protein, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Globular Protein, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Globular Protein, by Application USD Million (2018-2023)
  • Table 28. Asia Pacific Globular Protein, by End Use USD Million (2018-2023)
  • Table 29. China Globular Protein, by Type USD Million (2018-2023)
  • Table 30. China Globular Protein, by Application USD Million (2018-2023)
  • Table 31. China Globular Protein, by End Use USD Million (2018-2023)
  • Table 32. Japan Globular Protein, by Type USD Million (2018-2023)
  • Table 33. Japan Globular Protein, by Application USD Million (2018-2023)
  • Table 34. Japan Globular Protein, by End Use USD Million (2018-2023)
  • Table 35. India Globular Protein, by Type USD Million (2018-2023)
  • Table 36. India Globular Protein, by Application USD Million (2018-2023)
  • Table 37. India Globular Protein, by End Use USD Million (2018-2023)
  • Table 38. South Korea Globular Protein, by Type USD Million (2018-2023)
  • Table 39. South Korea Globular Protein, by Application USD Million (2018-2023)
  • Table 40. South Korea Globular Protein, by End Use USD Million (2018-2023)
  • Table 41. Taiwan Globular Protein, by Type USD Million (2018-2023)
  • Table 42. Taiwan Globular Protein, by Application USD Million (2018-2023)
  • Table 43. Taiwan Globular Protein, by End Use USD Million (2018-2023)
  • Table 44. Australia Globular Protein, by Type USD Million (2018-2023)
  • Table 45. Australia Globular Protein, by Application USD Million (2018-2023)
  • Table 46. Australia Globular Protein, by End Use USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Globular Protein, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Globular Protein, by Application USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Globular Protein, by End Use USD Million (2018-2023)
  • Table 50. Europe Globular Protein, by Country USD Million (2018-2023)
  • Table 51. Europe Globular Protein, by Type USD Million (2018-2023)
  • Table 52. Europe Globular Protein, by Application USD Million (2018-2023)
  • Table 53. Europe Globular Protein, by End Use USD Million (2018-2023)
  • Table 54. Germany Globular Protein, by Type USD Million (2018-2023)
  • Table 55. Germany Globular Protein, by Application USD Million (2018-2023)
  • Table 56. Germany Globular Protein, by End Use USD Million (2018-2023)
  • Table 57. France Globular Protein, by Type USD Million (2018-2023)
  • Table 58. France Globular Protein, by Application USD Million (2018-2023)
  • Table 59. France Globular Protein, by End Use USD Million (2018-2023)
  • Table 60. Italy Globular Protein, by Type USD Million (2018-2023)
  • Table 61. Italy Globular Protein, by Application USD Million (2018-2023)
  • Table 62. Italy Globular Protein, by End Use USD Million (2018-2023)
  • Table 63. United Kingdom Globular Protein, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Globular Protein, by Application USD Million (2018-2023)
  • Table 65. United Kingdom Globular Protein, by End Use USD Million (2018-2023)
  • Table 66. Netherlands Globular Protein, by Type USD Million (2018-2023)
  • Table 67. Netherlands Globular Protein, by Application USD Million (2018-2023)
  • Table 68. Netherlands Globular Protein, by End Use USD Million (2018-2023)
  • Table 69. Rest of Europe Globular Protein, by Type USD Million (2018-2023)
  • Table 70. Rest of Europe Globular Protein, by Application USD Million (2018-2023)
  • Table 71. Rest of Europe Globular Protein, by End Use USD Million (2018-2023)
  • Table 72. MEA Globular Protein, by Country USD Million (2018-2023)
  • Table 73. MEA Globular Protein, by Type USD Million (2018-2023)
  • Table 74. MEA Globular Protein, by Application USD Million (2018-2023)
  • Table 75. MEA Globular Protein, by End Use USD Million (2018-2023)
  • Table 76. Middle East Globular Protein, by Type USD Million (2018-2023)
  • Table 77. Middle East Globular Protein, by Application USD Million (2018-2023)
  • Table 78. Middle East Globular Protein, by End Use USD Million (2018-2023)
  • Table 79. Africa Globular Protein, by Type USD Million (2018-2023)
  • Table 80. Africa Globular Protein, by Application USD Million (2018-2023)
  • Table 81. Africa Globular Protein, by End Use USD Million (2018-2023)
  • Table 82. North America Globular Protein, by Country USD Million (2018-2023)
  • Table 83. North America Globular Protein, by Type USD Million (2018-2023)
  • Table 84. North America Globular Protein, by Application USD Million (2018-2023)
  • Table 85. North America Globular Protein, by End Use USD Million (2018-2023)
  • Table 86. United States Globular Protein, by Type USD Million (2018-2023)
  • Table 87. United States Globular Protein, by Application USD Million (2018-2023)
  • Table 88. United States Globular Protein, by End Use USD Million (2018-2023)
  • Table 89. Canada Globular Protein, by Type USD Million (2018-2023)
  • Table 90. Canada Globular Protein, by Application USD Million (2018-2023)
  • Table 91. Canada Globular Protein, by End Use USD Million (2018-2023)
  • Table 92. Mexico Globular Protein, by Type USD Million (2018-2023)
  • Table 93. Mexico Globular Protein, by Application USD Million (2018-2023)
  • Table 94. Mexico Globular Protein, by End Use USD Million (2018-2023)
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Globular Protein: by Type(USD Million)
  • Table 106. Globular Protein Recombinant Globular Protein , by Region USD Million (2025-2030)
  • Table 107. Globular Protein Bovine Globular Protein , by Region USD Million (2025-2030)
  • Table 108. Globular Protein Human Globular Protein , by Region USD Million (2025-2030)
  • Table 109. Globular Protein: by Application(USD Million)
  • Table 110. Globular Protein Therapeutics , by Region USD Million (2025-2030)
  • Table 111. Globular Protein Vaccine , by Region USD Million (2025-2030)
  • Table 112. Globular Protein Other , by Region USD Million (2025-2030)
  • Table 113. Globular Protein: by End Use(USD Million)
  • Table 114. Globular Protein Hospitals , by Region USD Million (2025-2030)
  • Table 115. Globular Protein Clinics , by Region USD Million (2025-2030)
  • Table 116. South America Globular Protein, by Country USD Million (2025-2030)
  • Table 117. South America Globular Protein, by Type USD Million (2025-2030)
  • Table 118. South America Globular Protein, by Application USD Million (2025-2030)
  • Table 119. South America Globular Protein, by End Use USD Million (2025-2030)
  • Table 120. Brazil Globular Protein, by Type USD Million (2025-2030)
  • Table 121. Brazil Globular Protein, by Application USD Million (2025-2030)
  • Table 122. Brazil Globular Protein, by End Use USD Million (2025-2030)
  • Table 123. Argentina Globular Protein, by Type USD Million (2025-2030)
  • Table 124. Argentina Globular Protein, by Application USD Million (2025-2030)
  • Table 125. Argentina Globular Protein, by End Use USD Million (2025-2030)
  • Table 126. Rest of South America Globular Protein, by Type USD Million (2025-2030)
  • Table 127. Rest of South America Globular Protein, by Application USD Million (2025-2030)
  • Table 128. Rest of South America Globular Protein, by End Use USD Million (2025-2030)
  • Table 129. Asia Pacific Globular Protein, by Country USD Million (2025-2030)
  • Table 130. Asia Pacific Globular Protein, by Type USD Million (2025-2030)
  • Table 131. Asia Pacific Globular Protein, by Application USD Million (2025-2030)
  • Table 132. Asia Pacific Globular Protein, by End Use USD Million (2025-2030)
  • Table 133. China Globular Protein, by Type USD Million (2025-2030)
  • Table 134. China Globular Protein, by Application USD Million (2025-2030)
  • Table 135. China Globular Protein, by End Use USD Million (2025-2030)
  • Table 136. Japan Globular Protein, by Type USD Million (2025-2030)
  • Table 137. Japan Globular Protein, by Application USD Million (2025-2030)
  • Table 138. Japan Globular Protein, by End Use USD Million (2025-2030)
  • Table 139. India Globular Protein, by Type USD Million (2025-2030)
  • Table 140. India Globular Protein, by Application USD Million (2025-2030)
  • Table 141. India Globular Protein, by End Use USD Million (2025-2030)
  • Table 142. South Korea Globular Protein, by Type USD Million (2025-2030)
  • Table 143. South Korea Globular Protein, by Application USD Million (2025-2030)
  • Table 144. South Korea Globular Protein, by End Use USD Million (2025-2030)
  • Table 145. Taiwan Globular Protein, by Type USD Million (2025-2030)
  • Table 146. Taiwan Globular Protein, by Application USD Million (2025-2030)
  • Table 147. Taiwan Globular Protein, by End Use USD Million (2025-2030)
  • Table 148. Australia Globular Protein, by Type USD Million (2025-2030)
  • Table 149. Australia Globular Protein, by Application USD Million (2025-2030)
  • Table 150. Australia Globular Protein, by End Use USD Million (2025-2030)
  • Table 151. Rest of Asia-Pacific Globular Protein, by Type USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Globular Protein, by Application USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Globular Protein, by End Use USD Million (2025-2030)
  • Table 154. Europe Globular Protein, by Country USD Million (2025-2030)
  • Table 155. Europe Globular Protein, by Type USD Million (2025-2030)
  • Table 156. Europe Globular Protein, by Application USD Million (2025-2030)
  • Table 157. Europe Globular Protein, by End Use USD Million (2025-2030)
  • Table 158. Germany Globular Protein, by Type USD Million (2025-2030)
  • Table 159. Germany Globular Protein, by Application USD Million (2025-2030)
  • Table 160. Germany Globular Protein, by End Use USD Million (2025-2030)
  • Table 161. France Globular Protein, by Type USD Million (2025-2030)
  • Table 162. France Globular Protein, by Application USD Million (2025-2030)
  • Table 163. France Globular Protein, by End Use USD Million (2025-2030)
  • Table 164. Italy Globular Protein, by Type USD Million (2025-2030)
  • Table 165. Italy Globular Protein, by Application USD Million (2025-2030)
  • Table 166. Italy Globular Protein, by End Use USD Million (2025-2030)
  • Table 167. United Kingdom Globular Protein, by Type USD Million (2025-2030)
  • Table 168. United Kingdom Globular Protein, by Application USD Million (2025-2030)
  • Table 169. United Kingdom Globular Protein, by End Use USD Million (2025-2030)
  • Table 170. Netherlands Globular Protein, by Type USD Million (2025-2030)
  • Table 171. Netherlands Globular Protein, by Application USD Million (2025-2030)
  • Table 172. Netherlands Globular Protein, by End Use USD Million (2025-2030)
  • Table 173. Rest of Europe Globular Protein, by Type USD Million (2025-2030)
  • Table 174. Rest of Europe Globular Protein, by Application USD Million (2025-2030)
  • Table 175. Rest of Europe Globular Protein, by End Use USD Million (2025-2030)
  • Table 176. MEA Globular Protein, by Country USD Million (2025-2030)
  • Table 177. MEA Globular Protein, by Type USD Million (2025-2030)
  • Table 178. MEA Globular Protein, by Application USD Million (2025-2030)
  • Table 179. MEA Globular Protein, by End Use USD Million (2025-2030)
  • Table 180. Middle East Globular Protein, by Type USD Million (2025-2030)
  • Table 181. Middle East Globular Protein, by Application USD Million (2025-2030)
  • Table 182. Middle East Globular Protein, by End Use USD Million (2025-2030)
  • Table 183. Africa Globular Protein, by Type USD Million (2025-2030)
  • Table 184. Africa Globular Protein, by Application USD Million (2025-2030)
  • Table 185. Africa Globular Protein, by End Use USD Million (2025-2030)
  • Table 186. North America Globular Protein, by Country USD Million (2025-2030)
  • Table 187. North America Globular Protein, by Type USD Million (2025-2030)
  • Table 188. North America Globular Protein, by Application USD Million (2025-2030)
  • Table 189. North America Globular Protein, by End Use USD Million (2025-2030)
  • Table 190. United States Globular Protein, by Type USD Million (2025-2030)
  • Table 191. United States Globular Protein, by Application USD Million (2025-2030)
  • Table 192. United States Globular Protein, by End Use USD Million (2025-2030)
  • Table 193. Canada Globular Protein, by Type USD Million (2025-2030)
  • Table 194. Canada Globular Protein, by Application USD Million (2025-2030)
  • Table 195. Canada Globular Protein, by End Use USD Million (2025-2030)
  • Table 196. Mexico Globular Protein, by Type USD Million (2025-2030)
  • Table 197. Mexico Globular Protein, by Application USD Million (2025-2030)
  • Table 198. Mexico Globular Protein, by End Use USD Million (2025-2030)
  • Table 199. Research Programs/Design for This Report
  • Table 200. Key Data Information from Secondary Sources
  • Table 201. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Globular Protein: by Type USD Million (2018-2023)
  • Figure 5. Global Globular Protein: by Application USD Million (2018-2023)
  • Figure 6. Global Globular Protein: by End Use USD Million (2018-2023)
  • Figure 7. South America Globular Protein Share (%), by Country
  • Figure 8. Asia Pacific Globular Protein Share (%), by Country
  • Figure 9. Europe Globular Protein Share (%), by Country
  • Figure 10. MEA Globular Protein Share (%), by Country
  • Figure 11. North America Globular Protein Share (%), by Country
  • Figure 12. Global Globular Protein share by Players 2023 (%)
  • Figure 13. Global Globular Protein share by Players (Top 3) 2023(%)
  • Figure 14. Global Globular Protein share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. CSL Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 17. CSL Limited (Australia) Revenue: by Geography 2023
  • Figure 18. Grifols (Spain) Revenue, Net Income and Gross profit
  • Figure 19. Grifols (Spain) Revenue: by Geography 2023
  • Figure 20. Shire (Baxalta) (United States) Revenue, Net Income and Gross profit
  • Figure 21. Shire (Baxalta) (United States) Revenue: by Geography 2023
  • Figure 22. Octapharma (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Octapharma (Switzerland) Revenue: by Geography 2023
  • Figure 24. Hualan Bio (China) Revenue, Net Income and Gross profit
  • Figure 25. Hualan Bio (China) Revenue: by Geography 2023
  • Figure 26. China Biologic Products Holdings Inc (China) Revenue, Net Income and Gross profit
  • Figure 27. China Biologic Products Holdings Inc (China) Revenue: by Geography 2023
  • Figure 28. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 29. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 30. Delta Biotechnology Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Delta Biotechnology Limited (United Kingdom) Revenue: by Geography 2023
  • Figure 32. LFB S.A. (France) Revenue, Net Income and Gross profit
  • Figure 33. LFB S.A. (France) Revenue: by Geography 2023
  • Figure 34. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Merck & Co. (United States) Revenue: by Geography 2023
  • Figure 36. Global Globular Protein: by Type USD Million (2025-2030)
  • Figure 37. Global Globular Protein: by Application USD Million (2025-2030)
  • Figure 38. Global Globular Protein: by End Use USD Million (2025-2030)
  • Figure 39. South America Globular Protein Share (%), by Country
  • Figure 40. Asia Pacific Globular Protein Share (%), by Country
  • Figure 41. Europe Globular Protein Share (%), by Country
  • Figure 42. MEA Globular Protein Share (%), by Country
  • Figure 43. North America Globular Protein Share (%), by Country
List of companies from research coverage that are profiled in the study
  • CSL Limited (Australia)
  • Grifols (Spain)
  • Shire (Baxalta) (United States)
  • Octapharma (Switzerland)
  • Hualan Bio (China)
  • China Biologic Products Holdings Inc (China)
  • Thermo Fisher Scientific (United States)
  • Delta Biotechnology Limited (United Kingdom)
  • LFB S.A. (France)
  • Merck & Co. (United States)
Additional players considered in the study are as follows:
Kedrion (United States) , Ventria (InVitria) (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 223 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Globular Protein Market Quantitative research analysis
Global Globular Protein Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as CSL Limited (Australia), Grifols (Spain), Shire (Baxalta) (United States), Octapharma (Switzerland), Hualan Bio (China), China Biologic Products Holdings Inc (China), Thermo Fisher Scientific (United States), Delta Biotechnology Limited (United Kingdom), LFB S.A. (France) and Merck & Co. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technical Progress in Biotech Industry" is seen as one of major influencing trends for Globular Protein Market during projected period 2023-2030.
The Globular Protein market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Globular Protein Market Report?

Have a Query? Click Here

Other Related Reports

Yeast Twohybrid System Comprehensive Study by Type (Protein-Protein Interaction, Protein-DNA Interaction), Application (Therapeutic, Industrial, Research), Form (Liquid, Tablet), Distribution Channel...
$ 3650
Biopharmaceutical Equipment Comprehensive Study by Type (Filtration Systems, Bioreactors, Extractors, Chromatography, Cell Culture, Bioprocessing Containers, Sterilizers, Others), Application (Biopro...
$ 3450
Algal Protein Expression System Comprehensive Study by Type (Reagents and Kits, Expression Vectors, Competent Cells, Instruments, Others), Application (Medical Research Institutions, Hospitals, Speci...
$ 3650
Biotinylated Polyclonal Antibodies Comprehensive Study by Type (Primary Antibody, Secondary Antibody), Application (Immunocytochemistry (ICC), Immunoprecipitation (IP), Western Blot (WB), In Situ Hyb...
$ 3500
Kinase Biology Tools and Services Comprehensive Study by Type (Reagents and Kits, Instruments, Accessories and Consumables), Application (Diagnosis, Research), End-User (Academic & Research Institute...
$ 3750
Aquaculture Vaccines Comprehensive Study by Type (Inactivated Vaccines, Live Vaccines), Application (Bacterial Infection, Viral Infection, Fungal Infections, Parasitic Infections), Route of Administr...
$ 3450